Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Lasserson TJ"'
Asthma patients who continue to experience symptoms despite being on regular inhaled corticosteroids (ICS) represent a management challenge. Long-acting beta2-agonists (LABA) or anti-leukotrienes (LTRA) are two treatment options that could be conside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::0974e86ccdf01cf957aa6290b438692d
https://openaccess.sgul.ac.uk/id/eprint/2678/1/CD003137.pdf
https://openaccess.sgul.ac.uk/id/eprint/2678/1/CD003137.pdf
Autor:
Cates, CJ, Lasserson, TJ
Background\ud Formoterol has a fast onset of action and can therefore be used to relieve symptoms of asthma. A combination inhaler can deliver formoterol with different doses of inhaled corticosteroid; when used as a reliever both drugs will be deliv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6f3edb9583b00a3cbb607c6975f181f2
https://openaccess.sgul.ac.uk/id/eprint/2693/1/CD007085.pdf
https://openaccess.sgul.ac.uk/id/eprint/2693/1/CD007085.pdf
Autor:
Cates, CJ, Lasserson, TJ
Background\ud Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy. The combination of formoterol and budesonide in a single inhaler introduces the possibility of using a single inhaler for both prevention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::cceacd1790e9f029fd4954684ca18cc6
https://openaccess.sgul.ac.uk/id/eprint/2692/1/CD007313.pdf
https://openaccess.sgul.ac.uk/id/eprint/2692/1/CD007313.pdf
Background\ud Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::39de2390a72d037d70d3b2834f54b9ea
https://openaccess.sgul.ac.uk/id/eprint/2695/1/CD006924.pdf
https://openaccess.sgul.ac.uk/id/eprint/2695/1/CD006924.pdf
Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe.Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7299b52b3aaf4a7571969b0e4e4fbc37
https://openaccess.sgul.ac.uk/id/eprint/2696/1/CD006922.pdf
https://openaccess.sgul.ac.uk/id/eprint/2696/1/CD006922.pdf
Publikováno v:
Education and Research Archive.
BACKGROUND: As chronic obstructive pulmonary disease (COPD) progresses, exacerbations can occur with increasing frequency. One goal of therapy in COPD is to try and prevent these exacerbations, thereby reducing disease morbidity and associated health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9cfed9c767b2ba802ef422d7629e1095
https://researchonline.lshtm.ac.uk/id/eprint/4840/1/Granger_et_al-2006-The_Cochrane_library.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4840/1/Granger_et_al-2006-The_Cochrane_library.pdf
Publikováno v:
The Cochrane Library
Background Pulmonary Hypertension (PH) can be either of unknown aetiology (primary pulmonary hypertension (PPH)) or due to a known underlying cause (secondary pulmonary hypertension (SPH). Pulmonary arteriolar vasoconstriction is considered to be an
Publikováno v:
The Cochrane Library
BACKGROUND Obstructive sleep apnoea/hypopnoea syndrome(OSAHS) is the periodic reduction or cessation of airflow during sleep. The syndrome is associated with loud snoring, disrupted sleep and observed apnoeas. Surgery for obstructive sleep apnoea/hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b695d6a7a5771ea12584c3595a0dfcc
https://doi.org/10.1002/14651858.cd001004
https://doi.org/10.1002/14651858.cd001004